Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,745 public trials 635 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

Mepo for Eosinophilic Esophagitis (EoE) Study

NCT03656380

Conditions
Digestive System Diseases, EoE, Eosinophilia, +11 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • MNGI Digestive Health, P.A. Minneapolis, Minnesota, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • University of Utah Salt Lake City, Utah, United States
View Trial Details
Completed

A Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic Dermatitis

NCT05121480

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • USA-131 Birmingham, Alabama, United States
  • USA-112 Fountain Valley, California, United States
  • USA-123 Fremont, California, United States
  • USA-114 Newport Beach, California, United States
View all 59 locations
View Trial Details
Completed

Children's Respiratory and Environmental Workgroup

NCT03213184

Conditions
Allergic Asthma, Allergies, Asthma, +9 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Boston University School of Medicine Boston, Massachusetts, United States
  • Henry Ford Health System Detroit, Michigan, United States
View Trial Details
Completed

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MTPS9579A in Patients With Asthma Requiring Inhaled Corticosteroids and a Second Controller

NCT04092582

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Kern Research Bakersfield, California, United States
  • Allergy & Asthma Medical Group of the Bay Area Walnut Creek, California, United States
  • Florida Ctr-Allergy & Asthma Miami, Florida, United States
  • Florida Pulmonary Research Institute, LLC Winter Park, Florida, United States
View all 27 locations
View Trial Details
Completed

Efficacy and Safety of Azelastine +Mometasone , Nasal Spray, 140 mcg + 50 mcg, (Sandoz d.d., Slovenia) and Momat Rino Advance, Nasal Spray, 140 mcg + 50 mcg, (Glenmark, India) Administered as a Monotherapy to Patients With Seasonal Allergic Rhinitis.

NCT05590598

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
Locations
  • Sandoz Investigative Site Chelyabinsk, Russia
  • Sandoz Investigative Site Khasavyurt, Russia
  • Sandoz Investigative Site Krasnodar, Russia
  • Sandoz Investigative Site Nal'chik, Russia
View all 15 locations
View Trial Details

Related conditions